Contact information
gary.ford@rdm.ox.ac.uk
gary.ford@ouh.nhs.uk
Jo Harrison
Jo-Anne.Harrison@oxfordahsn.org
Colleges
Gary Ford
FRCP, FMedSci
Professor of Stroke Medicine
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
Recent publications
-
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
Muir KW. et al, (2024), The Lancet Neurology, 23, 1087 - 1096
-
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
Werring DJ. et al, (2024), Lancet
-
Transient Ischaemic attack Emergency Referral (TIER): randomised feasibility trial results.
Watkins A. et al, (2024), Emerg Med J
-
A lifetime economic model of mortality and secondary care use for patients discharged from hospital following acute stroke.
McMeekin PJ. et al, (2024), Int J Stroke
-
Accessing mechanical thrombectomy treatment for stroke in England, Wales and Northern Ireland: the importance of the emergency pathway.
Price C. et al, (2024), Emerg Med J
ORCID
0000-0001-8719-4968